Financial News
Articles published by Verve Therapeutics
Verve Therapeutics Announces Updates on its PCSK9 Program
April 02, 2024
From Verve Therapeutics
Via GlobeNewswire
Tickers
VERV
Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
February 27, 2024
From Verve Therapeutics
Via GlobeNewswire
Tickers
VERV
Verve Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
February 01, 2024
From Verve Therapeutics
Via GlobeNewswire
Tickers
VERV
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
November 28, 2023
From Verve Therapeutics
Via GlobeNewswire
Tickers
VERV
Verve Therapeutics Announces Proposed Public Offering of Common Stock and Concurrent Private Placement
November 28, 2023
From Verve Therapeutics
Via GlobeNewswire
Tickers
VERV
Verve Therapeutics Highlights Recent Company Progress and Reports Third Quarter 2023 Financial Results
November 07, 2023
From Verve Therapeutics
Via GlobeNewswire
Tickers
VERV
Verve and Lilly Relationship Expands to Include Verve’s In Vivo Gene Editing Programs Targeting PCSK9 and ANGPTL3
October 31, 2023
From Verve Therapeutics
Via GlobeNewswire
Tickers
VERV
Verve Therapeutics to Participate in the 2023 Cantor Global Healthcare Conference
September 21, 2023
From Verve Therapeutics
Via GlobeNewswire
Tickers
VERV
Verve Expands Leadership Team with Appointment of Frederick T. Fiedorek, M.D., as Chief Medical Officer
September 18, 2023
From Verve Therapeutics
Via GlobeNewswire
Tickers
VERV
Verve Therapeutics Highlights Recent Company Progress and Reports Second Quarter 2023 Financial Results
August 10, 2023
From Verve Therapeutics
Via GlobeNewswire
Tickers
VERV
Verve Therapeutics to Participate in the RBC Capital Markets 2023 Global Healthcare Conference
May 09, 2023
From Verve Therapeutics
Via GlobeNewswire
Tickers
VERV
Verve Therapeutics to Participate in the Guggenheim 2023 Genomic Medicines and Rare Disease Day
March 27, 2023
From Verve Therapeutics
Via GlobeNewswire
Tickers
VERV
Verve Therapeutics to Participate in Upcoming Investor Conferences
November 11, 2022
From Verve Therapeutics
Via GlobeNewswire
Tickers
VERV
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.